TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for Phathom Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-10 06:10 am Sale |
2024-04-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 2,790,480 4.800% |
-362,737 (-11.50%) |
Filing |
| 2024-04-01 06:15 am Sale |
2024-03-28 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 3,153,217 5.400% |
-602,366 (-16.04%) |
Filing |
| 2024-01-25 06:11 am Sale |
2024-01-24 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 3,755,583 6.600% |
-3,703,721 (-49.65%) |
Filing |
| 2021-11-12 06:03 am Sale |
2021-11-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 7,459,304 19.200% |
-1,212,696 (-13.98%) |
Filing |
| 2021-04-06 06:05 am Unchanged |
2021-04-02 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 8,672,000 22.300% |
0 (Unchanged) |
Filing |
| 2021-04-01 06:06 am Unchanged |
2021-03-31 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 8,672,000 22.300% |
0 (Unchanged) |
Filing |